Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 34, Issue 1, Pages 57-62
http://dx.doi.org/10.3233/DMA-2012-0923

The Value of Combined Use of Survivin mRNA and Matrix Metalloproteinase 2 and 9 for Bladder Cancer Detection in Voided Urine

Sanaa Eissa,1 Soheir Badr,2 Shadia Abd Elhamid,3 Azza Salah Helmy,3 Mohamed Nour,2 and Mohamed Esmat4

1Biochemistry Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
2Oncolgy Diagnostic Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt
3Biochemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt
4Urology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Received 3 September 2012; Accepted 3 September 2012

Copyright © 2013 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Sanaa Eissa, Soheir Badr, Shadia Abd Elhamid, Azza Salah Helmy, Mohamed Nour, and Mohamed Esmat, “The Value of Combined Use of Survivin mRNA and Matrix Metalloproteinase 2 and 9 for Bladder Cancer Detection in Voided Urine,” Disease Markers, vol. 34, no. 1, pp. 57-62, 2013. https://doi.org/10.3233/DMA-2012-0923.